DIAMIDEX: Funding, Investors & Team (Sep 2026)
Established in 2014, DIAMIDEX is a pioneering company specializing in detecting and measuring microorganisms of interest. Its main goal is to make the invisible visible rapidly to aid in preventing microbial risks. The company's patented and innovative technological approach, developed by CNRS researchers, solves the challenges posed by microbiological culture in terms of speed and technicality. With a powerful and well-regarded technological platform, DIAMIDEX offers comprehensive test solutions that can be used in laboratories or in the field to provide a semi-quantitative count of cultured microorganisms up to 10 times faster than traditional culture methods. Currently focused on the microbiological testing market in water networks, DIAMIDEX is expanding its product range to meet market demands, particularly in the field of microbiological control in cosmetics.
DIAMIDEX has raised $2.7M across 1 funding round on record, the most recent an undisclosed round of $2.7M announced in Nov 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
DIAMIDEX Company Profile and Key Stats
Latest funding round on record: Nov 2023.
DIAMIDEX Funding Rounds
DIAMIDEX Founders and Leadership Team
No contact details are on record for this team yet.
DIAMIDEX Funding Compared to Other Biotechnology Startups
DIAMIDEX's latest round of $2.7M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like DIAMIDEX in Biotechnology and Marseille
Companies Similar to DIAMIDEX
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…
AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…
Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
AB Science was established in 2001 by a group of individuals in the medical and business fields who are…
DIAMIDEX Funding FAQs
What does DIAMIDEX do?
Established in 2014, DIAMIDEX is a pioneering company specializing in detecting and measuring microorganisms of interest. Its main goal is to make the invisible visible rapidly to aid in preventing microbial risks. The company's patented and innovative technological approach, developed by CNRS researchers, solves the challenges posed by microbiological culture in terms of speed and technicality. With a powerful and well-regarded technological platform, DIAMIDEX offers comprehensive test solutions that can be used in laboratories or in the field to provide a semi-quantitative count of cultured microorganisms up to 10 times faster than traditional culture methods. Currently focused on the microbiological testing market in water networks, DIAMIDEX is expanding its product range to meet market demands, particularly in the field of microbiological control in cosmetics.
How much funding has DIAMIDEX raised?
DIAMIDEX has raised $2.7M across 1 round on record. The most recent is an undisclosed round of $2.7M announced in Nov 2023.
When did DIAMIDEX last raise funding?
DIAMIDEX's most recent funding round on record is an undisclosed round of $2.7M, announced in Nov 2023.
Who founded DIAMIDEX?
FundedIQ lists Eric Agostini (Founder) at DIAMIDEX.
Where is DIAMIDEX headquartered?
DIAMIDEX is based in Marseille, Provence-Alpes-Cote D'azur, France.
How many employees does DIAMIDEX have?
DIAMIDEX is in the 11-50 employee band.
How does DIAMIDEX's funding compare to other Biotechnology startups?
DIAMIDEX's latest round of $2.7M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's DIAMIDEX Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for DIAMIDEX is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.